Schipke, C. G., Menne, F., Rubow, S., Sigle, J., Peters, O., & Grimmer, T. (2020). Value of a Panel of 6 Serum Biomarkers to Differentiate Between Healthy Controls and Mild Cognitive Impairment Due to Alzheimer Disease. Alzheimer disease and associated disorders, 34(4), 318. https://doi.org/10.1097/WAD.0000000000000397
Chicago Style (17th ed.) CitationSchipke, Carola G., Felix Menne, Stella Rubow, Jörg-Peter Sigle, Oliver Peters, and Timo Grimmer. "Value of a Panel of 6 Serum Biomarkers to Differentiate Between Healthy Controls and Mild Cognitive Impairment Due to Alzheimer Disease." Alzheimer Disease and Associated Disorders 34, no. 4 (2020): 318. https://doi.org/10.1097/WAD.0000000000000397.
MLA (9th ed.) CitationSchipke, Carola G., et al. "Value of a Panel of 6 Serum Biomarkers to Differentiate Between Healthy Controls and Mild Cognitive Impairment Due to Alzheimer Disease." Alzheimer Disease and Associated Disorders, vol. 34, no. 4, 2020, p. 318, https://doi.org/10.1097/WAD.0000000000000397.